Corvus Pharmaceuticals News

Latest Corvus Pharmaceuticals Stock News & CRVS Headlines

Corvus Pharmaceuticals: Durability, Not Peak Efficacy, Is The Real Product

6 days ago | seekingalpha.com

Corvus: 'Strong Buy' On Continued Soquelitinib Advancement And HS Data 1st Half 2027

6 days ago | seekingalpha.com

Corvus Pharmaceuticals, Inc. (CRVS) Q3 2026 Earnings Call Transcript

9 days ago | seekingalpha.com

What Corvus Pharmaceuticals (CRVS) Said on Its Q3 Earnings Call

10 days ago | marketbeat.com

Corvus Pharmaceuticals Announces Initial Data from Soquelitinib Clinical Trial in Patients with Autoimmune Lymphoproliferative Syndrome (ALPS) will be Presented at the 68ᵗʰ American Society for Hematology Annual Meeting & Exposition

12 days ago | globenewswire.com

Corvus Pharmaceuticals to Provide Business Update and Third Quarter 2026 Financial Results on November 5, 2026

18 days ago | globenewswire.com

Corvus Pharmaceuticals (NASDAQ:CRVS) Shares Gap Up – Still a Buy?

a month ago | defenseworld.net

Corvus Pharmaceuticals Announces Initiation of Phase 1b Clinical Trial of Soquelitinib for Patients with Hidradenitis Suppurativa

2 months ago | globenewswire.com

Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1b T Cell Lymphoma Trial

3 months ago | globenewswire.com

Corvus Pharmaceuticals, Inc. (CRVS) Q2 2026 Earnings Call Transcript

3 months ago | seekingalpha.com

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

Market Closed

CRVS

Corvus Pharmaceuticals

$ 10.64

0.19%

Last 24H

Trading with leverage comes with a high risk and may not be suitable for everyone.

Portfolio

Updated 2 days ago

Top

Gainers

Losers

Symbol

Last Price

24H CNG

Corvus Pharmaceuticals News

Latest Corvus Pharmaceuticals Stock News & CRVS Headlines

Download App

People Also Watch

Explore our Tools